Launch-HTN, the largest trial of an aldosterone synthase inhibitor conducted among participants with uncontrolled or treatment-resistant ...
HTN, the largest trial of an aldosterone synthase inhibitor conducted among participants with uncontrolled or treatment-resistant hypertension, was one of nine studies selected as most impactful ...
Oncolytics Biotech Inc. (NASDAQ: ONCY) has secured FDA alignment on its pivotal Phase 3 study design for pelareorep in ...
Oncolytics Biotech Inc. (NASDAQ: ONCY) has secured FDA alignment on its pivotal Phase 3 study design for pelareorep in first-line metastatic pancreatic cancer, positioning the company to launch the ...
Baystreet.ca News Commentary – Artificial intelligence and platform-based approaches reshaped cancer treatment development in ...
Trofinetide is a synthetic analog of the N-terminal tripeptide of insulin-like growth factor 1. The mechanism by which ...
Morning Overview on MSN
Scientists reveal a hidden brain switch that speeds habit formation
Habits can feel mysterious, arriving almost overnight or refusing to stick despite weeks of effort. New work on a “hidden ...
News Medical on MSN
AI-guided discovery of selective DGKα inhibitors to overcome checkpoint resistance in solid cancers
Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) designed to restore T cell function and overcome resistance to immune checkpoint ...
Verywell Health on MSN
What Happens to Your Blood Sugar and Immune System When You Take Elderberry?
Curious how elderberry supplements affects blood sugar and the immune system? Learn what current research shows—plus safety ...
Detailed price information for Oncotelic Therapeutics Inc (OTLC) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback